An update on therapeutic strategies and clinical trials in dementia

This session will review potential treatment strategies for dementia based on inflammation, protein handling, glucose metabolism and tau phosphorylation and clinical trials which target these.

Chair: Professor John O'Brien, University of Cambridge

Inflammation as a therapeutic target in alzheimer's disease - Dr Vanessa Raymont, University of Oxford

Lithium and other inhibitors of tau phosphorylation - Dr Ross Dunne, University of Manchester

Protein production, degradation and glucose metabolism -Dr Ben Underwood, University of Cambridge